RESOLUTION
Live / Registered — Registered (as of 28 Jun 2022)
What this means for you
Registered since 28 Jun 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90130276
- Registration number
- 6770463
- Mark type
- Stylized text
- Filed
- 21 Aug 2020
- Published for opposition
- 12 Apr 2022
- Registered
- 28 Jun 2022
- Attorney of record
- Rebecca Liebowitz
Goods and services
- Class 001 — Chemicals: Cells for scientific purposes; molecular biology research tools in the nature of biological, chemical and biochemical reagents for research use; biological preparations for cell therapy
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of hematologic diseases, immune response disorders, neurological disorders, respiratory diseases, ophthalmological conditions, metabolic diseases, genetic conditions, cancer, infectious diseases and cardiovascular diseases; medical and veterinary preparations for therapeutic purposes for the treatment of hematologic diseases, immune response disorders, neurological disorders, respiratory diseases, ophthalmological conditions, metabolic diseases, genetic conditions, cancer, infectious diseases and cardiovascular diseases; cells for medical or veterinary use; pharmaceutical and biopharmaceutical preparations for modifying human or animal cells for medical or therapeutic purposes; pharmaceutical and biopharmaceutical preparations of cells from humans or animals which have been adapted for medical or therapeutic purposes
- Class 040 — Treatment of materials: Treatment and processing of biological materials; custom manufacture of therapeutic drugs, namely, custom manufacture of cells and cell therapies
- Class 042 — Scientific and technological services: Scientific and technological services and research and design relating thereto, namely, scientific research in the field of in the fields of haematology, immunology, neurology, respiratory diseases, ophthalmology, metabolic conditions, genetic conditions, oncology, immuno-oncology, infectious diseases and cardiovascular diseases; industrial research services, in the field of cell therapies and gene therapies; chemical and biological analysis and research services; scientific research in human and animal cell therapy; scientific research into preparations for manipulating and adapting human and animal cells; design and development of new products for others; scientific laboratory services, namely, manipulation of human and animal cells for therapeutic purposes ; advisory and consultancy relating to all the aforesaid services
- Class 044 — Medical, beauty and agricultural services: Medical and veterinary research services including the manipulation of biological reagents to be used for medical or therapeutic purposes; medical and veterinary research services including the manipulation of cells within a laboratory or research facility to enable the cells to be used for medical or therapeutic purposes; veterinary services; medical services in the nature of extraction of human and animal cells from patients; medical services, namely, reinsertion of cells into human and animal patients; providing advice and consultancy in the field of medical and veterinary therapies
Owner
- Resolution Therapeutics Limited, London, GB
- Resolution Therapeutics Limited, London, GB
- Resolution Therapeutics Limited, London, GB
Prosecution history
- 28 Jun 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 28 Jun 2022 — REGISTERED-PRINCIPAL REGISTER
- 12 Apr 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 12 Apr 2022 — PUBLISHED FOR OPPOSITION
- 23 Mar 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 08 Mar 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 07 Feb 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 07 Feb 2022 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 02 Feb 2022 — ASSIGNED TO LIE
- 26 Jan 2022 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 27 Jul 2021 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 27 Jul 2021 — NON-FINAL ACTION E-MAILED
- 27 Jul 2021 — NON-FINAL ACTION WRITTEN
- 24 Jun 2021 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 24 Jun 2021 — CORRESPONDENCE RECEIVED IN LAW OFFICE